Currently out of the existing stock ratings of David Buck, 32 are a BUY (84.21%), 5 are a HOLD (13.16%), 1 are a SELL (2.63%).

David Buck

Work Performance Price Targets & Ratings Chart

Analyst David Buck, carries an average stock price target met ratio of 43.75% that have a potential upside of 29.44% achieved within 205 days. Previously, David Buck worked at B. RILEY.

David Buck’s has documented 76 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CORT, Corcept Therapeutics at 05-Feb-2019.

Wall Street Analyst David Buck

Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 12/31/2018. The price target of $21 was fulfilled within 25 days with a profit of $5.2 (32.91%) receiving and performance score of 13.16.

Average potential price target upside

of $48.81 (38.85%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $12.82 (59.78%) on SUPN (SUPERNUS PHARMACEUTICALS).
of $6.71 (53.65%) on CORT (CORCEPT THERAPEUTICS).

JAZZ Jazz Pharmaceuticals PLC MNK Mallinckrodt plc AMAG AMAG Pharmaceuticals SPPI Spectrum Pharmaceuticals SUPN Supernus Pharmaceuticals ALKS Alkermes Plc CORT Corcept Therapeutics ENDP Endo International PLC PRGO Perrigo Company PLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Ami Fadia (NEEDHAM)